60 Degrees Pharmaceuticals (SXTP) Income Statement (2022 - 2026)
Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for 60 Degrees Pharmaceuticals (SXTP).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||
Total Revenue | 160K (-46.67%) | 300K (-31.82%) | 440K (+340.00%) | 100K (-37.50%) | 160K (-33.33%) | 240K (+71.43%) | 140K (+16.67%) | 120K (+9.09%) | 110K (-15.38%) | 130K (+160.00%) | 50K (-16.67%) | 60K (+200.00%) | 20K (+100.00%) | 10K (-94.12%) | 170K (+240.00%) | 50K | - |
Cost Of Revenue | 90K (-25.00%) | 120K (-77.78%) | 540K (+980.00%) | 50K (-28.57%) | 70K (-41.67%) | 120K (+9.09%) | 110K (+22.22%) | 90K (+28.57%) | 70K (-53.33%) | 150K (+114.29%) | 70K (-61.11%) | 180K (+157.14%) | 70K (-72.00%) | 250K (+177.78%) | 90K (0.00%) | 90K | - |
Costof Goods And Services Sold | 90K (-25.00%) | 120K (-77.78%) | 540K (+980.00%) | 50K (-28.57%) | 70K (-41.67%) | 120K (+9.09%) | 110K (+22.22%) | 90K (+28.57%) | 70K (-53.33%) | 150K (+114.29%) | 70K (-61.11%) | 180K (+157.14%) | 70K (-72.00%) | 250K (+177.78%) | 90K (0.00%) | 90K | - |
Gross Profit | 80K (-55.56%) | 180K | -100.00K | 50K (-44.44%) | 90K (-25.00%) | 120K (+500.00%) | 20K (-50.00%) | 40K (0.00%) | 40K | -20.00K (0.00%) | -20.00K (-83.33%) | -120.00K (+100.00%) | -60.00K (-75.00%) | -240.00K | 80K | -40.00K | - |
Operating Expenses | |||||||||||||||||
Research And Development | 280K (-58.82%) | 680K (-16.05%) | 810K (+224.00%) | 250K (-32.43%) | 370K (-39.34%) | 610K (-35.11%) | 940K (-69.68%) | 3.10M (+811.76%) | 340K (+240.00%) | 100K (-61.54%) | 260K (+30.00%) | 200K (+66.67%) | 120K (-55.56%) | 270K (+800.00%) | 30K (-86.96%) | 230K | - |
Selling General And Administrative | 1.89M (+31.25%) | 1.44M (-4.64%) | 1.51M (-6.21%) | 1.61M (-6.40%) | 1.72M (+6.83%) | 1.61M (+31.97%) | 1.22M (+7.96%) | 1.13M (+4.63%) | 1.08M (-36.09%) | 1.69M (+29.01%) | 1.31M (+184.78%) | 460K (-41.03%) | 780K (+62.50%) | 480K (+17.07%) | 410K (0.00%) | 410K | - |
Operating Expenses | 2.17M (+2.84%) | 2.11M (-9.05%) | 2.32M (+24.73%) | 1.86M (-11.00%) | 2.09M (-5.86%) | 2.22M (+2.78%) | 2.16M (-48.82%) | 4.22M (+199.29%) | 1.41M (-21.23%) | 1.79M (+13.29%) | 1.58M (+135.82%) | 670K (-25.56%) | 900K (+20.00%) | 750K (+70.45%) | 440K (-31.25%) | 640K | - |
Depreciation And Amortization | 20K (0.00%) | 20K (+100.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - |
Operating Income | |||||||||||||||||
Operating Income | -2.09M (+8.85%) | -1.92M (-17.60%) | -2.33M (+45.63%) | -1.60M (-16.23%) | -1.91M (-7.73%) | -2.07M (-2.36%) | -2.12M (-49.40%) | -4.19M (+212.69%) | -1.34M (-29.10%) | -1.89M (+24.34%) | -1.52M (+92.41%) | -790.00K (-16.84%) | -950.00K (+11.76%) | -850.00K (+286.36%) | -220.00K (-68.12%) | -690.00K | - |
Ebit | -2.09M (+8.85%) | -1.92M (-17.60%) | -2.33M (+45.63%) | -1.60M (-16.23%) | -1.91M (-7.73%) | -2.07M (-2.36%) | -2.12M (-49.40%) | -4.19M (+212.69%) | -1.34M (-29.10%) | -1.89M (+24.34%) | -1.52M (+92.41%) | -790.00K (-16.84%) | -950.00K | 60K | -220.00K (-68.12%) | -690.00K (-24.18%) | -910.00K |
EBITDA | -2.08M (+9.47%) | -1.90M (-17.75%) | -2.31M (+44.38%) | -1.60M (-15.79%) | -1.90M (-7.77%) | -2.06M (-2.37%) | -2.11M (-49.64%) | -4.19M (+212.69%) | -1.34M (-29.10%) | -1.89M (+24.34%) | -1.52M (+94.87%) | -780.00K (-17.02%) | -940.00K (+571.43%) | -140.00K (-33.33%) | -210.00K (-69.12%) | -680.00K (-1.45%) | -690.00K |
Other Income / Expenses | |||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | 10K (-75.00%) | 40K (-96.36%) | 1.10M (-3.51%) | 1.14M (-30.91%) | 1.65M (+35.25%) | 1.22M (+34.07%) | 910K (+333.33%) | 210K |
Net Interest Income | - | - | - | - | - | - | - | - | - | -10.00K (-75.00%) | -40.00K (-96.36%) | -1.10M (-3.51%) | -1.14M (-39.04%) | -1.87M (+53.28%) | -1.22M (+34.07%) | -910.00K | - |
Other Non Operating Income | 10K (-92.31%) | 130K (+333.33%) | 30K (+200.00%) | 10K (-66.67%) | 30K (-70.00%) | 100K (+400.00%) | 20K (0.00%) | 20K (-33.33%) | 30K | -80.00K (+14.29%) | -70.00K | - | - | -40.00K | - | - | - |
Net Income | |||||||||||||||||
Income Before Tax | -2.09M (+45.14%) | -1.44M (-37.93%) | -2.32M (+34.10%) | -1.73M (-7.98%) | -1.88M (-8.29%) | -2.05M (-5.09%) | -2.16M (-48.20%) | -4.17M | 430K | -2.05M | 4.17M | -3.34M (+28.46%) | -2.60M (+0.78%) | -2.58M (+77.93%) | -1.45M (-32.56%) | -2.15M | - |
Net Income From Continuing Operations | -2.09M (+45.14%) | -1.44M (-37.93%) | -2.32M (+34.10%) | -1.73M (-7.98%) | -1.88M (-8.29%) | -2.05M (-5.09%) | -2.16M (-48.20%) | -4.17M | 430K | -2.01M | 4.18M | -3.34M (+28.46%) | -2.60M (+54.76%) | -1.68M (+15.86%) | -1.45M (-32.56%) | -2.15M (+136.26%) | -910.00K |
Net Income | -2.09M (+45.14%) | -1.44M (-37.93%) | -2.32M (+34.10%) | -1.73M (-7.98%) | -1.88M (-8.29%) | -2.05M (-5.09%) | -2.16M (-48.20%) | -4.17M | 430K | -2.01M | 4.18M | -3.34M (+28.46%) | -2.60M (+54.76%) | -1.68M (+15.86%) | -1.45M (-32.56%) | -2.15M (+136.26%) | -910.00K |
Comprehensive Income Net Of Tax | -2.08M (-71.74%) | -7.36M (+217.24%) | -2.32M (+34.88%) | -1.72M (-8.99%) | -1.89M (-76.23%) | -7.95M (+268.06%) | -2.16M (-48.20%) | -4.17M | 430K | -3.70M | 4.19M | -3.34M (+28.46%) | -2.60M (-57.93%) | -6.18M (+326.21%) | -1.45M (-35.84%) | -2.26M | - |